This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LCDR James W. Steger, MD; Alfred Hollander, MD
San Diego

Arch Dermatol. 1982;118(9):625-626.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In the November 1981 ARCHIVES (117:698-700), Lowe and Breeding stated that "Anthralin was first introduced by Galewsky as a therapeutic agent for skin disease in 1916 under the name `chrysarobin.'" Historically, this statement is incorrect, and it should have read ". . . under the name cignolin." A correct translation of the title of Galewsky's article,¹ (cited as reference 1 in their article) would be "Cignolin [anthralin], a substitute for chrysarobin." Because of the renewed interest in anthralin therapy for psoriasis in recent years, we thought a reexamination of the early history of anthralin and its predecessor chrysarobin would be of interest.

Chrysarobin is one of the extracts of Goa powder, a substance found deposited in the wood of Andira araró ba, a native tree of India.² Goa powder had long been used by the native population in India for the treatment of skin diseases, especially of ringworm. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?